Soteria Biotherapeutics Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
19
- Latest Deal Type
-
Out of Business
Soteria Biotherapeutics General Information
Description
Developer of next generation of switchable bispecific T-cell engagers intended to treat cancer patients with solid tumors. The company's platform provides small molecule-dependent activation of bispecific antibody therapies, enabling healthcare professionals to provide safer and more efficacious treatments through pulsatile activity and reduced side effects.
Contact Information
Website
www.soteriabiotherapeutics.comCorporate Office
- 1900 Alameda De Las Pulgas
- Suite 250
- San Mateo, CA 94403
- United States
Corporate Office
- 1900 Alameda De Las Pulgas
- Suite 250
- San Mateo, CA 94403
- United States
Soteria Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 06-Jun-2025 | Completed | Out of Business | |||
| 3. Secondary Transaction - Private | 15-Jun-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 17-May-2021 | $42M | $42M | Completed | Generating Revenue | |
| 1. Grant | 01-Jan-2019 | $300K | Completed | Generating Revenue |
Soteria Biotherapeutics Comparisons
Industry
Financing
Details
Soteria Biotherapeutics Competitors (59)
One of Soteria Biotherapeutics’s 59 competitors is Cristal Therapeutics, a Venture Capital-Backed company based in Maastricht, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
| Geneos Therapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Ayala Pharmaceuticals | Corporation | Wilmington, DE |
Soteria Biotherapeutics Patents
Soteria Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022150792-A1 | Indinavir based chemical dimerization t cell engager compositions | Inactive | 11-Jan-2021 | ||
| WO-2022026939-A2 | Single and dual targeting ligand induced t-cell engager compositions | Inactive | 31-Jul-2020 | ||
| WO-2022026939-A3 | Single and dual targeting ligand induced t-cell engager compositions | Inactive | 31-Jul-2020 | ||
| AU-2020415451-A1 | Chemically induced association and dissociation of therapeutic fc compositions and chemically induced dimerization of t cell engager with human serum albumin | Inactive | 23-Dec-2019 | ||
| CA-3163035-A1 | Chemically induced association and dissociation of therapeutic fc compositions and chemically induced dimerization of t cell engager with human serum albumin | Pending | 23-Dec-2019 | C07K16/2803 |
Soteria Biotherapeutics Signals
Soteria Biotherapeutics FAQs
-
When was Soteria Biotherapeutics founded?
Soteria Biotherapeutics was founded in 2018.
-
Where is Soteria Biotherapeutics headquartered?
Soteria Biotherapeutics is headquartered in San Mateo, CA.
-
What is the size of Soteria Biotherapeutics?
Soteria Biotherapeutics has 19 total employees.
-
What industry is Soteria Biotherapeutics in?
Soteria Biotherapeutics’s primary industry is Drug Discovery.
-
Is Soteria Biotherapeutics a private or public company?
Soteria Biotherapeutics is a Private company.
-
What is Soteria Biotherapeutics’s current revenue?
The current revenue for Soteria Biotherapeutics is .
-
How much funding has Soteria Biotherapeutics raised over time?
Soteria Biotherapeutics has raised $42M.
-
Who are Soteria Biotherapeutics’s competitors?
Cristal Therapeutics, Geneos Therapeutics, Centrose, Adaptimmune Therapeutics, and Ayala Pharmaceuticals are some of the 59 competitors of Soteria Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process